최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기응용통계연구 = The Korean journal of applied statistics, v.34 no.2, 2021년, pp.255 - 266
김빛나 (강원대학교 통계학과) , 이민정 (강원대학교 통계학과)
The purpose of this study is to compare the effects of treatment on stage III stomach cancer data obtained from the SEER program of the National Cancer Institute and to identify the significant risk factors for the survival rates of stage III stomach cancer. Since the proportional hazards assumption...
Andersen PK, Hansen MG, and Klein JP (2004). Regression analysis of restricted mean survival time based on pseudo-observations, Lifetime Data Analysis, 10, 335-350.
Andersen PK and Perme MP (2010). Pseudo-observations in survival analysis, Statistical Methods in Medical Research, 19, 71-99.
Chen PY and Tsiatis AA (2001). Causal inference on the difference of the restricted mean lifetime between two groups, Biometrics, 57, 1030-1038.
Cox DR (1972). Regression models and life-tables (with discussion), Journal of Royal Statistical Society, Series A, 34, 187-220.
Grambsch P and Therneau T (1994). Proportional hazards tests and diagnostics based on weighted residuals, Biometrika, 81 ,515-526.
Guo C and Liang Y (2019). Analyzing restricted mean survival time using SAS/STAT, SAS Institute Inc., Cary, NC.
Irwin JO (1949). The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice, The Journal of Hygiene, 47, 188-189.
Kaplan EL and Meier P (1958). Nonparametric estimation from incomplete observations, Journal of the American Statistical Association, 53, 457-481.
Korea Central Cancer Registry (2019). National cancer center, Annual report of cancer statistics in Korea in 2017, Ministry of health and welfare.
Liang KY and Zeger SL (1986). Longitudinal data analysis using generalized linear models, Biometrika, 73, 13-22.
National Cancer Information Center (2019). Cancer information service. from: https://www.cancer.go.kr/
Nemes S, Bulow E, and Gustavsson A (2020). A brief overview of restricted mean survival time estimators and associated variances, MDPI Stats, 3, 107-119.
Prentice RL (1978). Linear rank tests with right censored data, Biometrike, 65, 167-180.
Royston P and Parmar MK (2011). The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt, Statistics in Medicine, 30, 2409-2421.
Ruhl J, Ward E, Hofferkamp J, et al (2019). Grade Manual. NAACCR, Springfield, IL 62704-4194.
Schoenfeld D (1982). Partial residuals for the proportional hazards regression model, Biometrika, 69, 239-241.
Surveillance, Epidemiology, and End results (SEER) program (www.seer.cancer.gov) SEER*Stat Database : Incidence - SEER 18 Regs custom data (with additional treatment fields), Nov 2018 Sub (1975-2016 varying) - Linked to county attributes - total US, 1969-2017 counties, national cancer institute, DCCPS, Surveillance research program, released April 2019, based on the November 2018 submission.
Tian L, Zhao L, and Wei LJ (2014). Predicting the Restricted mean event time with the subject's baseline covariates in survival analysis, Biostatistics, 15, 222-233.
Zeger SL and Liang KY (1986). Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121-130.
Zhao L, Tian L, Uno H, Solomon SD, Pfeffer MA, Schindler JS, and Wei LJ (2012). Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study, Clinical Trials, 9, 570-577.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.